Area of research
Infectious Diseases · Endocrinology, Diabetes and Metabolism
Research interest
Research interests include Medicine, Cohort, Coronavirus disease 2019 (COVID-19), Internal medicine, Pediatrics, and 2019-20 coronavirus outbreak.
Risk of Thyroid Tumors With GLP-1 Receptor Agonists: A Retrospective Cohort Study
Comparative Effectiveness of Second-Line Antihyperglycemic Agents for Cardiovascular Outcomes
Similar Risk of Kidney Failure among Patients with Blinding Diseases Who Receive Ranibizumab, Aflibercept, and Bevacizumab
A deep learning-based electrocardiogram risk score for long term cardiovascular death and disease
Multinational patterns of second line antihyperglycaemic drug initiation across cardiovascular risk groups: federated pharmacoepidemiological evaluation in LEGEND-T2DM
Contextualising adverse events of special interest to characterise the baseline incidence rates in 24 million patients with COVID-19 across 26 databases: a multinational retrospective cohort study
Characteristics and outcomes of COVID-19 patients with COPD from the United States, South Korea, and Europe
Large-scale evidence generation and evaluation across a network of databases for type 2 diabetes mellitus (LEGEND-T2DM): a protocol for a series of multinational, real-world comparative cardiovascular effectiveness and safety studies
Unraveling COVID-19: A Large-Scale Characterization of 4.5 Million COVID-19 Cases Using CHARYBDIS
Characterising the background incidence rates of adverse events of special interest for covid-19 vaccines in eight countries: multinational network cohort study
COVID-19 in patients with autoimmune diseases: characteristics and outcomes in a multinational network of cohorts across three countries
Implementation of the COVID-19 Vulnerability Index Across an International Network of Health Care Data Sets: Collaborative External Validation Study
Characteristics and outcomes of patients with COVID-19 with and without prevalent hypertension: a multinational cohort study
Risk of hydroxychloroquine alone and in combination with azithromycin in the treatment of rheumatoid arthritis: a multinational, retrospective study
Deep phenotyping of 34,128 adult patients hospitalised with COVID-19 in an international network study
Risk of depression, suicide and psychosis with hydroxychloroquine treatment for rheumatoid arthritis: a multinational network cohort study